SCHEMBL8551784

SCHEMBL8551784

COC(=O)COc1ccc(NC(=O)c2cnc(C3CCN(C(=O)OCc4ccccc4)CC3)s2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
ENPP2 Q13822 1/20 0.45
NPC1 O15118 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 2/20 0.43
USP30 Q70CQ3 1/20 0.42
GRIN2B Q13224 7/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP3A4 P08684 2/20 0.42
FLT3 P36888 1/20 0.41
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551545 0.90 ENPP2 (0.42) ENPP2NPC1SMN1; SMN2RAB9AMEN1
SCHEMBL8551127 0.85 LMNA (0.45) HTTENPP2NPC1SMN1; SMN2RAB9A
SCHEMBL8553111 0.80 SMN1; SMN2 (0.56) HTTNPC1SMN1; SMN2RAB9AMEN1
SCHEMBL8553852 0.78 HTT (0.45) HTTENPP2NPC1SMN1; SMN2RAB9A
Bromide SCHEMBL8551319 0.78 POLB (0.44) HTTMEN1KMT2AALDH1A1
SCHEMBL8626081 0.77 SMN1; SMN2 (0.51) HTTNPC1SMN1; SMN2RAB9AMEN1
SCHEMBL8552625 0.74 LMNA (0.46) HTTENPP2MEN1KMT2ALMNA
SCHEMBL23201424 0.74 SMN1; SMN2 (0.57) HTTNPC1SMN1; SMN2RAB9AMEN1
SCHEMBL8551494 0.73 PRMT5 (0.48) HTTNPC1SMN1; SMN2RAB9AMEN1
Hydrochloric Acid SCHEMBL8549386 0.73 POLB (0.48) HTTNPC1SMN1; SMN2RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0858457-A1 5-MEMBERED HETEROCYCLES, PHARMACEUTICAL AGENTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF AND METHODS OF PRODUCING THEM Dr. Karl Thomae GmbH (DE) 1998-08-19 EP disclosed
WO-1997015567-A1 5-MEMBERED HETEROCYCLES, PHARMACEUTICAL AGENTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF AND METHODS OF PRODUCING THEM DR. KARL THOMAE GMBH (DE) 1997-05-01 WO disclosed